NCT04164901 · Interventional trial
Study of Vorasidenib (AG-881) in Participants With Residual or Recurrent Grade 2 Glioma With an IDH1 or IDH2 Mutation (INDIGO)
Overall registry status Active not recruiting
Phase 3
Conditions Grade 2 Glioma, Recurrent Glioma, Residual Glioma
Delaware Valley sites
- University of Pennsylvania · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory